![Theis Kipling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 209 594 $ al 31/05/2026
Theis Kipling is currently Chief Executive Officer at Biovica International AB since 2026.
Formerly, Mr. Kipling was Chief Commercial Officer at Devyser Diagnostics AB from 2022 to 2026 and Chief Commercial Officer at Atlas Antibodies AB.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DEVYSER DIAGNOSTICS AB 0,12 % | 31/12/2024 | 20.809 ( 0,12 % ) | 209 594 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Director Ejecutivo | 01/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Corporate Officer/Principal | 01/05/2026 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
